Literature DB >> 12747773

Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.

Robert Pearlstein1, Roy Vaz, David Rampe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747773     DOI: 10.1021/jm0205651

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  18 in total

1.  State dependent dissociation of HERG channel inhibitors.

Authors:  D Stork; E N Timin; S Berjukow; C Huber; A Hohaus; M Auer; S Hering
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

2.  Shape signatures: new descriptors for predicting cardiotoxicity in silico.

Authors:  Dmitriy S Chekmarev; Vladyslav Kholodovych; Konstantin V Balakin; Yan Ivanenkov; Sean Ekins; William J Welsh
Journal:  Chem Res Toxicol       Date:  2008-05-08       Impact factor: 3.739

3.  Cardio-vascular safety beyond hERG: in silico modelling of a guinea pig right atrium assay.

Authors:  Luca A Fenu; Ard Teisman; Stefan S De Buck; Vikash K Sinha; Ron A H J Gilissen; Marjoleen J M A Nijsen; Claire E Mackie; Wendy E Sanderson
Journal:  J Comput Aided Mol Des       Date:  2009-11-05       Impact factor: 3.686

4.  Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.

Authors:  Shawn P Walsh; Aurash Shahripour; Haifeng Tang; Nardos Teumelsan; Jessica Frie; Yuping Zhu; Birgit T Priest; Andrew M Swensen; Jessica Liu; Michael Margulis; Richard Visconti; Adam Weinglass; John P Felix; Richard M Brochu; Timothy Bailey; Brande Thomas-Fowlkes; Magdalena Alonso-Galicia; Xiaoyan Zhou; Lee-Yuh Pai; Aaron Corona; Caryn Hampton; Melba Hernandez; Ross Bentley; Jing Chen; Kashmira Shah; Joseph Metzger; Michael Forrest; Karen Owens; Vincent Tong; Sookhee Ha; Sophie Roy; Gregory J Kaczorowski; Lihu Yang; Emma Parmee; Maria L Garcia; Kathleen Sullivan; Alexander Pasternak
Journal:  ACS Med Chem Lett       Date:  2015-05-07       Impact factor: 4.345

5.  Comparative study of the structure and interaction of the pore helices of the hERG and Kv1.5 potassium channels in model membranes.

Authors:  Maïwenn Beaugrand; Alexandre A Arnold; Steve Bourgault; Philip T F Williamson; Isabelle Marcotte
Journal:  Eur Biophys J       Date:  2017-03-17       Impact factor: 1.733

6.  Novel Bayesian classification models for predicting compounds blocking hERG potassium channels.

Authors:  Li-li Liu; Jing Lu; Yin Lu; Ming-yue Zheng; Xiao-min Luo; Wei-liang Zhu; Hua-liang Jiang; Kai-xian Chen
Journal:  Acta Pharmacol Sin       Date:  2014-06-30       Impact factor: 6.150

7.  4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl- N-benzylpyrrolidine-3-carboxamides.

Authors:  Marvin J Meyers; Jianguang Liu; Jing Xu; Fang Leng; Jiantong Guan; Zhijun Liu; Sarah A McNitt; Limei Qin; Linglin Dai; Hongwei Ma; Dickson Adah; Siting Zhao; Xiaofen Li; Alex J Polino; Armiyaw S Nasamu; Daniel E Goldberg; Xiaorong Liu; Yongzhi Lu; Zhengchao Tu; Xiaoping Chen; Micky D Tortorella
Journal:  J Med Chem       Date:  2019-03-22       Impact factor: 7.446

8.  Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.

Authors:  Jiesheng Kang; David R Compton; Roy J Vaz; David Rampe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-16       Impact factor: 3.000

Review 9.  HERG1 channel agonists and cardiac arrhythmia.

Authors:  Michael C Sanguinetti
Journal:  Curr Opin Pharmacol       Date:  2013-11-27       Impact factor: 5.547

Review 10.  Strategies to reduce the risk of drug-induced QT interval prolongation: a pharmaceutical company perspective.

Authors:  C E Pollard; J-P Valentin; T G Hammond
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.